A systematic review supporting the Society for Vascular Surgery guidelines on the management of heritable aortopathies

To support the development of clinical practice guidelines on the management of patients with genetic aortopathies and arteriopathies, a writing committee from the Society for Vascular Surgery has commissioned this systematic review. We conducted a systematic review and searched multiple databases f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of vascular surgery 2023-10, Vol.78 (4), p.1077-1082.e12
Hauptverfasser: Firwana, Mohammed, Hasan, Bashar, Saadi, Samer, Abd-Rabu, Rami, Alabdallah, Khaled, Al-Zu'bi, Hossam, Shalhub, Sherene, Black, James H., Prokop, Larry J., Murad, M. Hassan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1082.e12
container_issue 4
container_start_page 1077
container_title Journal of vascular surgery
container_volume 78
creator Firwana, Mohammed
Hasan, Bashar
Saadi, Samer
Abd-Rabu, Rami
Alabdallah, Khaled
Al-Zu'bi, Hossam
Shalhub, Sherene
Black, James H.
Prokop, Larry J.
Murad, M. Hassan
description To support the development of clinical practice guidelines on the management of patients with genetic aortopathies and arteriopathies, a writing committee from the Society for Vascular Surgery has commissioned this systematic review. We conducted a systematic review and searched multiple databases for studies addressing six questions identified by the Society for Vascular Surgery guideline committee about evaluating and managing patients with genetic aortopathies and arteriopathies. Studies were selected and appraised by pairs of independent reviewers. We included 12 studies in this systematic review. We did not identify studies about the long-term outcomes of endovascular repair for aortic aneurysm in patients with heritable aortopathy or about new aortic events in pregnant women with a history of aortic dissection (AD) or aneurysm. A small case series demonstrated a 100% survival rate and 100% aortic intervention-free survival at 15 months (range, 7-28 months) after endograft repair for type B AD. A positive genetic diagnosis was discovered in 36% of patients with aortic aneurysms and dissections who had no risk factors for hereditary aortopathies, and these patients had a mortality rate of 11% at a median follow-up duration of 5 months. Black patients had lower 30-day mortality than White patients (5.6% vs 9.0%, respectively), but they had a higher overall aortic reintervention rate at 30 days after AD repair (47% vs 27%, respectively). Aortic reinterventions owing to aneurysmal expansion and endoleak at 30 days were higher in Black patients than White patients. The certainty of evidence was judged to be very low across all the outcomes evaluated in this systematic review. The available evidence suggests high survival after thoracic endovascular aortic repair for type B AD in young patients with heritable aortopathies, but with limited long-term follow-up. Genetic testing in patients with acute aortic aneurysms and dissections had a high yield. It was positive for most patients with risk factors for hereditary aortopathies and in more than one-third for all other patients, and was associated with new aortic events within 15 years.
doi_str_mv 10.1016/j.jvs.2023.06.004
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2827260520</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S074152142301306X</els_id><sourcerecordid>2827260520</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-a8cf238bd3b28cec04e8b95288494fdb4db6862699f9b46547202fff49ddf5cc3</originalsourceid><addsrcrecordid>eNp9kE-P1CAYh4nRuOPqB_BiOHppBUopxNNm479kEw-rXgmFlxkmbalAx8y3l3VWj57ey_N7kvdB6DUlLSVUvDu2x1NuGWFdS0RLCH-CdpSooRGSqKdoRwZOm55RfoVe5HwkhNJeDs_RVTd0bFB9t0OnG5zPucBsSrA4wSnAL5y3dY2phGWPywHwfbQByhn7mPAPk-02mYTvt7SHdMb7LTiYwgIZx-UPPpvF7GGGpeDo8QFSKGacAJuqjKsphwD5JXrmzZTh1eO9Rt8_fvh2-7m5-_rpy-3NXWM7JUpjpPWsk6PrRiYtWMJBjqpnUnLFvRu5G4UUTCjl1chFz4caw3vPlXO-t7a7Rm8v3jXFnxvkoueQLUyTWSBuWTPJBiZIz0hF6QW1KeacwOs1hdmks6ZEP-TWR11z64fcmghdc9fNm0f9Ns7g_i3-9q3A-wsA9cnaNulcWy4WXEhgi3Yx_Ef_G5E_k0k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2827260520</pqid></control><display><type>article</type><title>A systematic review supporting the Society for Vascular Surgery guidelines on the management of heritable aortopathies</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Firwana, Mohammed ; Hasan, Bashar ; Saadi, Samer ; Abd-Rabu, Rami ; Alabdallah, Khaled ; Al-Zu'bi, Hossam ; Shalhub, Sherene ; Black, James H. ; Prokop, Larry J. ; Murad, M. Hassan</creator><creatorcontrib>Firwana, Mohammed ; Hasan, Bashar ; Saadi, Samer ; Abd-Rabu, Rami ; Alabdallah, Khaled ; Al-Zu'bi, Hossam ; Shalhub, Sherene ; Black, James H. ; Prokop, Larry J. ; Murad, M. Hassan</creatorcontrib><description>To support the development of clinical practice guidelines on the management of patients with genetic aortopathies and arteriopathies, a writing committee from the Society for Vascular Surgery has commissioned this systematic review. We conducted a systematic review and searched multiple databases for studies addressing six questions identified by the Society for Vascular Surgery guideline committee about evaluating and managing patients with genetic aortopathies and arteriopathies. Studies were selected and appraised by pairs of independent reviewers. We included 12 studies in this systematic review. We did not identify studies about the long-term outcomes of endovascular repair for aortic aneurysm in patients with heritable aortopathy or about new aortic events in pregnant women with a history of aortic dissection (AD) or aneurysm. A small case series demonstrated a 100% survival rate and 100% aortic intervention-free survival at 15 months (range, 7-28 months) after endograft repair for type B AD. A positive genetic diagnosis was discovered in 36% of patients with aortic aneurysms and dissections who had no risk factors for hereditary aortopathies, and these patients had a mortality rate of 11% at a median follow-up duration of 5 months. Black patients had lower 30-day mortality than White patients (5.6% vs 9.0%, respectively), but they had a higher overall aortic reintervention rate at 30 days after AD repair (47% vs 27%, respectively). Aortic reinterventions owing to aneurysmal expansion and endoleak at 30 days were higher in Black patients than White patients. The certainty of evidence was judged to be very low across all the outcomes evaluated in this systematic review. The available evidence suggests high survival after thoracic endovascular aortic repair for type B AD in young patients with heritable aortopathies, but with limited long-term follow-up. Genetic testing in patients with acute aortic aneurysms and dissections had a high yield. It was positive for most patients with risk factors for hereditary aortopathies and in more than one-third for all other patients, and was associated with new aortic events within 15 years.</description><identifier>ISSN: 0741-5214</identifier><identifier>EISSN: 1097-6809</identifier><identifier>DOI: 10.1016/j.jvs.2023.06.004</identifier><identifier>PMID: 37327953</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aortic dissections ; Genetically triggered thoracic aortic disease ; Heritable thoracic aortic disease ; Marfan syndrome ; Systematic review ; Thoracic aortic aneurysms ; Type B aortic dissection</subject><ispartof>Journal of vascular surgery, 2023-10, Vol.78 (4), p.1077-1082.e12</ispartof><rights>2023 Society for Vascular Surgery</rights><rights>Copyright © 2023 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-a8cf238bd3b28cec04e8b95288494fdb4db6862699f9b46547202fff49ddf5cc3</citedby><cites>FETCH-LOGICAL-c396t-a8cf238bd3b28cec04e8b95288494fdb4db6862699f9b46547202fff49ddf5cc3</cites><orcidid>0000-0002-1994-8219 ; 0000-0001-9225-1197 ; 0000-0002-8501-2750 ; 0000-0003-4713-624X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S074152142301306X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37327953$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Firwana, Mohammed</creatorcontrib><creatorcontrib>Hasan, Bashar</creatorcontrib><creatorcontrib>Saadi, Samer</creatorcontrib><creatorcontrib>Abd-Rabu, Rami</creatorcontrib><creatorcontrib>Alabdallah, Khaled</creatorcontrib><creatorcontrib>Al-Zu'bi, Hossam</creatorcontrib><creatorcontrib>Shalhub, Sherene</creatorcontrib><creatorcontrib>Black, James H.</creatorcontrib><creatorcontrib>Prokop, Larry J.</creatorcontrib><creatorcontrib>Murad, M. Hassan</creatorcontrib><title>A systematic review supporting the Society for Vascular Surgery guidelines on the management of heritable aortopathies</title><title>Journal of vascular surgery</title><addtitle>J Vasc Surg</addtitle><description>To support the development of clinical practice guidelines on the management of patients with genetic aortopathies and arteriopathies, a writing committee from the Society for Vascular Surgery has commissioned this systematic review. We conducted a systematic review and searched multiple databases for studies addressing six questions identified by the Society for Vascular Surgery guideline committee about evaluating and managing patients with genetic aortopathies and arteriopathies. Studies were selected and appraised by pairs of independent reviewers. We included 12 studies in this systematic review. We did not identify studies about the long-term outcomes of endovascular repair for aortic aneurysm in patients with heritable aortopathy or about new aortic events in pregnant women with a history of aortic dissection (AD) or aneurysm. A small case series demonstrated a 100% survival rate and 100% aortic intervention-free survival at 15 months (range, 7-28 months) after endograft repair for type B AD. A positive genetic diagnosis was discovered in 36% of patients with aortic aneurysms and dissections who had no risk factors for hereditary aortopathies, and these patients had a mortality rate of 11% at a median follow-up duration of 5 months. Black patients had lower 30-day mortality than White patients (5.6% vs 9.0%, respectively), but they had a higher overall aortic reintervention rate at 30 days after AD repair (47% vs 27%, respectively). Aortic reinterventions owing to aneurysmal expansion and endoleak at 30 days were higher in Black patients than White patients. The certainty of evidence was judged to be very low across all the outcomes evaluated in this systematic review. The available evidence suggests high survival after thoracic endovascular aortic repair for type B AD in young patients with heritable aortopathies, but with limited long-term follow-up. Genetic testing in patients with acute aortic aneurysms and dissections had a high yield. It was positive for most patients with risk factors for hereditary aortopathies and in more than one-third for all other patients, and was associated with new aortic events within 15 years.</description><subject>Aortic dissections</subject><subject>Genetically triggered thoracic aortic disease</subject><subject>Heritable thoracic aortic disease</subject><subject>Marfan syndrome</subject><subject>Systematic review</subject><subject>Thoracic aortic aneurysms</subject><subject>Type B aortic dissection</subject><issn>0741-5214</issn><issn>1097-6809</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kE-P1CAYh4nRuOPqB_BiOHppBUopxNNm479kEw-rXgmFlxkmbalAx8y3l3VWj57ey_N7kvdB6DUlLSVUvDu2x1NuGWFdS0RLCH-CdpSooRGSqKdoRwZOm55RfoVe5HwkhNJeDs_RVTd0bFB9t0OnG5zPucBsSrA4wSnAL5y3dY2phGWPywHwfbQByhn7mPAPk-02mYTvt7SHdMb7LTiYwgIZx-UPPpvF7GGGpeDo8QFSKGacAJuqjKsphwD5JXrmzZTh1eO9Rt8_fvh2-7m5-_rpy-3NXWM7JUpjpPWsk6PrRiYtWMJBjqpnUnLFvRu5G4UUTCjl1chFz4caw3vPlXO-t7a7Rm8v3jXFnxvkoueQLUyTWSBuWTPJBiZIz0hF6QW1KeacwOs1hdmks6ZEP-TWR11z64fcmghdc9fNm0f9Ns7g_i3-9q3A-wsA9cnaNulcWy4WXEhgi3Yx_Ef_G5E_k0k</recordid><startdate>20231001</startdate><enddate>20231001</enddate><creator>Firwana, Mohammed</creator><creator>Hasan, Bashar</creator><creator>Saadi, Samer</creator><creator>Abd-Rabu, Rami</creator><creator>Alabdallah, Khaled</creator><creator>Al-Zu'bi, Hossam</creator><creator>Shalhub, Sherene</creator><creator>Black, James H.</creator><creator>Prokop, Larry J.</creator><creator>Murad, M. Hassan</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1994-8219</orcidid><orcidid>https://orcid.org/0000-0001-9225-1197</orcidid><orcidid>https://orcid.org/0000-0002-8501-2750</orcidid><orcidid>https://orcid.org/0000-0003-4713-624X</orcidid></search><sort><creationdate>20231001</creationdate><title>A systematic review supporting the Society for Vascular Surgery guidelines on the management of heritable aortopathies</title><author>Firwana, Mohammed ; Hasan, Bashar ; Saadi, Samer ; Abd-Rabu, Rami ; Alabdallah, Khaled ; Al-Zu'bi, Hossam ; Shalhub, Sherene ; Black, James H. ; Prokop, Larry J. ; Murad, M. Hassan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-a8cf238bd3b28cec04e8b95288494fdb4db6862699f9b46547202fff49ddf5cc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Aortic dissections</topic><topic>Genetically triggered thoracic aortic disease</topic><topic>Heritable thoracic aortic disease</topic><topic>Marfan syndrome</topic><topic>Systematic review</topic><topic>Thoracic aortic aneurysms</topic><topic>Type B aortic dissection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Firwana, Mohammed</creatorcontrib><creatorcontrib>Hasan, Bashar</creatorcontrib><creatorcontrib>Saadi, Samer</creatorcontrib><creatorcontrib>Abd-Rabu, Rami</creatorcontrib><creatorcontrib>Alabdallah, Khaled</creatorcontrib><creatorcontrib>Al-Zu'bi, Hossam</creatorcontrib><creatorcontrib>Shalhub, Sherene</creatorcontrib><creatorcontrib>Black, James H.</creatorcontrib><creatorcontrib>Prokop, Larry J.</creatorcontrib><creatorcontrib>Murad, M. Hassan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of vascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Firwana, Mohammed</au><au>Hasan, Bashar</au><au>Saadi, Samer</au><au>Abd-Rabu, Rami</au><au>Alabdallah, Khaled</au><au>Al-Zu'bi, Hossam</au><au>Shalhub, Sherene</au><au>Black, James H.</au><au>Prokop, Larry J.</au><au>Murad, M. Hassan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A systematic review supporting the Society for Vascular Surgery guidelines on the management of heritable aortopathies</atitle><jtitle>Journal of vascular surgery</jtitle><addtitle>J Vasc Surg</addtitle><date>2023-10-01</date><risdate>2023</risdate><volume>78</volume><issue>4</issue><spage>1077</spage><epage>1082.e12</epage><pages>1077-1082.e12</pages><issn>0741-5214</issn><eissn>1097-6809</eissn><abstract>To support the development of clinical practice guidelines on the management of patients with genetic aortopathies and arteriopathies, a writing committee from the Society for Vascular Surgery has commissioned this systematic review. We conducted a systematic review and searched multiple databases for studies addressing six questions identified by the Society for Vascular Surgery guideline committee about evaluating and managing patients with genetic aortopathies and arteriopathies. Studies were selected and appraised by pairs of independent reviewers. We included 12 studies in this systematic review. We did not identify studies about the long-term outcomes of endovascular repair for aortic aneurysm in patients with heritable aortopathy or about new aortic events in pregnant women with a history of aortic dissection (AD) or aneurysm. A small case series demonstrated a 100% survival rate and 100% aortic intervention-free survival at 15 months (range, 7-28 months) after endograft repair for type B AD. A positive genetic diagnosis was discovered in 36% of patients with aortic aneurysms and dissections who had no risk factors for hereditary aortopathies, and these patients had a mortality rate of 11% at a median follow-up duration of 5 months. Black patients had lower 30-day mortality than White patients (5.6% vs 9.0%, respectively), but they had a higher overall aortic reintervention rate at 30 days after AD repair (47% vs 27%, respectively). Aortic reinterventions owing to aneurysmal expansion and endoleak at 30 days were higher in Black patients than White patients. The certainty of evidence was judged to be very low across all the outcomes evaluated in this systematic review. The available evidence suggests high survival after thoracic endovascular aortic repair for type B AD in young patients with heritable aortopathies, but with limited long-term follow-up. Genetic testing in patients with acute aortic aneurysms and dissections had a high yield. It was positive for most patients with risk factors for hereditary aortopathies and in more than one-third for all other patients, and was associated with new aortic events within 15 years.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>37327953</pmid><doi>10.1016/j.jvs.2023.06.004</doi><orcidid>https://orcid.org/0000-0002-1994-8219</orcidid><orcidid>https://orcid.org/0000-0001-9225-1197</orcidid><orcidid>https://orcid.org/0000-0002-8501-2750</orcidid><orcidid>https://orcid.org/0000-0003-4713-624X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0741-5214
ispartof Journal of vascular surgery, 2023-10, Vol.78 (4), p.1077-1082.e12
issn 0741-5214
1097-6809
language eng
recordid cdi_proquest_miscellaneous_2827260520
source Elsevier ScienceDirect Journals Complete
subjects Aortic dissections
Genetically triggered thoracic aortic disease
Heritable thoracic aortic disease
Marfan syndrome
Systematic review
Thoracic aortic aneurysms
Type B aortic dissection
title A systematic review supporting the Society for Vascular Surgery guidelines on the management of heritable aortopathies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T20%3A35%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20systematic%20review%20supporting%20the%20Society%20for%20Vascular%20Surgery%20guidelines%20on%20the%20management%20of%20heritable%20aortopathies&rft.jtitle=Journal%20of%20vascular%20surgery&rft.au=Firwana,%20Mohammed&rft.date=2023-10-01&rft.volume=78&rft.issue=4&rft.spage=1077&rft.epage=1082.e12&rft.pages=1077-1082.e12&rft.issn=0741-5214&rft.eissn=1097-6809&rft_id=info:doi/10.1016/j.jvs.2023.06.004&rft_dat=%3Cproquest_cross%3E2827260520%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2827260520&rft_id=info:pmid/37327953&rft_els_id=S074152142301306X&rfr_iscdi=true